1. Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. Mar 1 2015;136(5):E359–386.
2. Cheng X, Cai S, Li Z, Tang M, Xue M, Zang R. The prognosis of women with stage IB1–IIB node-positive cervical carcinoma after radical surgery. World journal of surgical oncology. 2004;2:47.
3. Graflund M, Sorbe B, Karlsson M. Immunohistochemical expression of p53, bcl–2, and p21(WAF1/CIP1) in early cervical carcinoma: correlation with clinical outcome. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society. May–Jun 2002;12(3):290–298.
4. Aoki Y, Sasaki M, Watanabe M, et al. High-risk group in node-positive patients with stage IB, IIA, and IIB cervical carcinoma after radical hysterectomy and postoperative pelvic irradiation. Gynecologic oncology. May 2000;77(2):305–309.
5. Sakuragi N, Satoh C, Takeda N, et al. Incidence and distribution pattern of pelvic and paraaortic lymph node metastasis in patients with Stages IB, IIA, and IIB cervical carcinoma treated with radical hysterectomy. Cancer. Apr 1 1999;85(7):1547–1554.